×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北京... [8]
合肥物质科学研究院 [2]
吉林大学白求恩第一医... [1]
复旦大学上海医学院 [1]
内容类型
期刊论文 [10]
会议论文 [2]
发表日期
2023 [1]
2022 [1]
2018 [5]
2017 [2]
2016 [1]
2014 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共12条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:
Bachy, Emmanuel
;
Savage, Kerry J.
;
Huang, Huiqiang
;
Kwong, Yok-Lam
;
Gritti, Giuseppe
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2023/11/10
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Bachy, Emmanuel
;
Savage, Kerry J.
;
Huang, Huiqiang
;
Kwong, Yok-Lam
;
Gritti, Giuseppe
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/12/23
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial
期刊论文
BLOOD, 2018, 卷号: 132
作者:
Wang, Aihua
;
Hilger, James
;
Huang, Jane
;
Novotny, William
;
Osman, Muhtar
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/12/05
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial
会议论文
作者:
Song, Yuqin
;
Zhou, Keshu
;
Zou, Dehui
;
Zhou, Jianfeng
;
Hu, Jianda
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11
期刊论文
2018, 卷号: 58, 页码: 27-34
作者:
Zhou, Keshu
;
Feng, Xiaoyan
;
Wang, Yanying
;
Liu, Yanyan
;
Tian, Long
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial
期刊论文
2018, 卷号: 132
作者:
Song, Yuqin
;
Zhou, Keshu
;
Zou, Dehui
;
Zhou, Jianfeng
;
Hu, Jianda
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial
会议论文
BLOOD, 2018-11-29
作者:
Song, Yuqin
;
Zhou, Keshu
;
Zou, Dehui
;
Zhou, Jianfeng
;
Hu, Jianda
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
MiRNA-223 functions as both prognostic biomarker and tumor suppressor in mantle cell lymphoma through targeting SOX11
期刊论文
2017
作者:
Zhou Keshu
;
Feng Xiaoyan
;
Wang Yanying
;
Liu Yanyan
;
Tian Long
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
SOX11
mantle cell lymphoma
miRNA
prognosis
Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia
期刊论文
2017, 卷号: 19, 期号: 2, 页码: 182-191
作者:
Yi, Shuhua
;
Li, Zengjun
;
Zou, Dehui
;
An, Gang
;
Cui, Rui
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/04
chronic lymphocytic leukemia
cytogenetic aberration
intratumoral subdone
prognosis
survival
The polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese population
期刊论文
2016, 卷号: 27, 期号: 1, 页码: 26-31
作者:
Zhou, Hu
;
Yang, Jingyi
;
Liu, Liu
;
Zhang, Donglei
;
Zhou, Keshu
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/04
Chinese
polymorphism
primary immune thrombocytopenia
tumor necrosis factor-induced protein 3 gene
©版权所有 ©2017 CSpace - Powered by
CSpace